Current and historical daily PE Ratio for Orphazyme AS (
CHIX:ORPHAc
) from 2021 to Jun 23 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Orphazyme AS stock (CHIX:ORPHAc) PE ratio as of Jun 23 2024 is 0.
More Details
Orphazyme AS (CHIX:ORPHAc) PE Ratio (TTM) Chart
Orphazyme AS (CHIX:ORPHAc) PE Ratio (TTM) Historical Data
View and export this data going back to 2021. Start your Free Trial
Total 0
- 1
| Orphazyme AS PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
Orphazyme AS (CHIX:ORPHAc) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Orphazyme AS
ISIN : DK0062502894
Share Class Description:
CHIX:ORPHAc: Ordinary SharesCompare
Compare
Traded in other countries / regions
ORPHA.Denmark1TB0.Germany0CUM.UKOZYMF.USA IPO Date
2021-06-16Description
Orphazyme AS has defined a new technique and has currently entered into a strategic partnership with the Swedish-listed company CombiGene AB. The company objects to engage in activities and investments related to biopharmaceutical research and development.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers